Indication
Extensive Stage Small Cell Lung Carcinoma
2 clinical trials
4 products
Product
HTMC0435Clinical trial
A Phase 1b/2, Dose-finding and Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HTMC0435 With Temozolomide in Patients With Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2024-08-01
Product
TemozolomideClinical trial
A Phase 2 Study of Continuous Talazoparib Plus Intermittent Low-Dose Temozolomide in Patients With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer (TRIO-US L-07)Status: Recruiting, Estimated PCD: 2024-10-01
Product
TalazoparibProduct
TMZ